Tag: TPIV

Blue Horseshoe Stocks: SPY Options Recap & More

SPY Options Update

We were so spot-on with our options alert on the SPY in yesterday’s premarket report, that we feel it necessary to quote our alert verbatim. We stated: “With another reversal appearing likely with this morning’s gap-up in the markets, we’ll want to swing our attention in the opposite direction. The SPY generally trades inversely to the UXVY, thus we’ll be monitoring SPY Weekly $195-197 Calls in the event of a continued uptrend signal.” 

We certainly hope a good number of our readers were able to catch that, as every single one of the contract sets in our targeted range could have facilitated sizable gains on the session. Here’s a breakdown of the possibilities:

$195 Calls  – Daily Range: 2.05-3.50 – Max Gain: 71%
$195.50 Calls  – Daily Range: 1.75-3.15 – Max Gain: 80%
$196 Calls  – Daily Range: 1.48-2.80 – Max Gain: 89%
$196.50 Calls  – Daily Range: 1.25-2.45 – Max Gain: 96%
$197 Calls  – Daily Range: 1.01-2.15 – Max Gain: 113%

In order to take advantage of the SPY moving forward, we’ll need to see a continued boost in stocks. In that event, we may look to roll our strike prices closer to the money, namely the Weekly $198-200.50 Calls.

Apple to Announce iPhone 6S Plus – Options Idea

With Apple officially announcing the release of the iPhone 7 today, which is slated to go on sale at the end of next week, we’re going to want to stay ready for the possibility of an options play to one side or the other. We’ll need to guage public reaction to the new phone; an underwhelming product could result in a PPS decline for AAPL, in which case we’d be monitoring Weekly $112-50-114.50 Puts. In the event of a mainly positive reaction, of course, we’d flip that idea to the Call-side in the same strike price range.

Akebia Therapeutics, Inc. AKBA

AKBA is undergoing a mega gap-up in premarket trading today, largely due to yesterday’s after-hours report of positive Phase II study results. We’ll look to possibly take advantage of the situation; with such a rapid move up, it leaves AKBA open to a dip-and-rip pattern on the chart when sellers come out of the woodwork to take profits off of the table.

We’ve pointed out the previous swing highs as levels at which AKBA will need to maintain support on the dip, in order for us to remain interested:

Akebia Announces Positive Top-Line Results from its Phase 2 Study of Vadadustat in Dialysis Patients with Anemia Related to Chronic Kidney Disease (Tue, Sep 8)

Extended Watchlist:
UAPC, CCTC, TPIV, ASTI

Blue Horseshoe Stocks: TPIV Recap, PZOO News & More

TapImmune, Inc. TPIV

Despite already being on one heck of a run, as we were stating in yesterday’s morning report, TPIV ended up having another landmark session in which it would surge to its highest PPS in almost a year.

The stock posted an early low of 1.20 before breaking out to 1.71, which registered as an intraday spike of 43% and occurred on heavy volume. TPIV also took the title of most actively-traded stock on the OTC for yesterday’s session, with shares changing hands 3,388 times.

We want to congratulate anyone who’s been tracking TPIV along with us recently; the total increase we’ve now observed in just eight sessions is equal to 137% (.72-1.71).

Yesterday’s continued uptrend was aided by the following PR:
TapImmune Reports Robust Immune Responses Generated in 19 of 20 Evaluable HER2/neu Breast Cancer Patients (Tue, Jun 23)

Pazoo, Inc. PZOO

Those of our subscribers that have joined our ranks in the past few weeks will need a little bringing up to speed on PZOO. We introduced this play at the beginning of April, and tracked it over an epic run from .0049 to .0204, which amounted to a 316% swing.

It has been nearly four weeks since we touched base with this play, and with a fresh PR released this morning, we think now would be a good time  to take another look. The stock has done well maintaining support throughout the month of June, trading in a channel between .009 to .011, holding a good bit of the advances we witnessed earlier in the Spring.

The storyline we’ve been following on PZOO of its 40% ownership in MA & associates, a Nevada-based marijuana testing agency, just got a whole lot more interesting with PZOO officially announcing that it has acquired the remaining 60% stake:

WHIPPANY, N.J., June 24, 2015 /PRNewswire/ — Pazoo, Inc. (OTC Pinks: PZOO) is pleased to report that on Wednesday, June 3, 2015,  Pazoo acquired the remaining 60% of MA & Associates, LLC in exchange for 900,000 shares of Pazoo’s Series C. Preferred stock. This now makes MA & Associates, LLC a 100% wholly-owned subsidiary of Pazoo. >>FULL PR

The MaryJane Group, Inc. MJMJ

MJMJ was among several stocks we tagged for potential upcoming bottom-plays at the end of last week, and while it did take the call an extra session to materialize, it did end up making that rebound yesterday.

The stock traded in a range from .0027-.0038; which marks an intraday swing of 41% on more than twice the average monthly volume. We’ll continue to monitor activity in the stock as the week progresses.

Under Armour, Inc. UA – Options

Yesterday morning, we updated readers as to the performance of the 07/31 $84 Calls that we initially alerted on Friday. From our observed low of 2.76, these contracts pushed further upward yesterday, extending to a new high of 4.20.

That pushes the overall range we’ve witnessed in just a two-session span to a respectable 52% We’ll continue to stay attuned to the activity as long as UA continues to perform well.

Extended Watchlist:
CPXX, NSPR, MEET, GBSN,

Blue Horseshoe Stocks: Options Update & Much More

Amedica Corp. AMDA

After providing us with the chance for intraweek gains of 61% last week, as we were mentioning in yesterday’s morning report, AMDA turned in another healthy performance for the day.

From a morning low of .58, the stock pressed to a new high of .70; a 21% intraday move, and this morning the stock is gapping up once again. As of this morning’s premarket high, the total range we’ve now observed in AMDA in just a week’s time stands at 102% from last Tuesday’s low of .3851.

Yesterday’s solid showing also marked the fifth consecutive trading day that AMDA managed to register higher lows and higher highs. We’ll continue to track its activity as the week progresses. A dip-and-rip off of this morning’s new high is a distinct possibility.

Under Armour, Inc. UA – Options Update

UA was a point of focus for us on Friday morning, at which time we submitted a medium-term options idea for the stock, namely the 07/31 $84 Calls. We wanted to provide an update on the subsequent performance of those contracts, which managed a notable increase between Friday and yesterday.

From a low of 2.76, the July $84’s have traded as high as 3.53 thus far. That hashes out to total possible gains of 28% over just a couple of trading sessions. With plenty of time left until expiration, we’ll be sure to keep a slot reserved for those contracts from this point forward.

TapImmune, Inc. TPIV

We’ve been tracking TPIV for nearly two weeks now. We tagged it for the first time on June 10th, and we slipped a reminder into Friday’s report as well.

We certainly hope those alerts caught someone’s attention, because TPIV has certainly caught ours; yesterday’s high of 1.23 represented a 28% jump from the low following Friday’s alert (.962) and an overall increase of 71% from the low following our initial alert (.72).

Sipp Industries, Inc. SIPC

SIPC is catching our attention this morning after announcing the addition of “Hemp co-packing, storage, distribution, and private label solutions to product offering.” in an early PR. It caused us to take notice of the chart, which is currently boasting an attractive setup with regard to its potential as a bottom-play. We’re going to keep a close eye on SIPC as we head into mid-week.

Extended Watchlist:
PHMD, BIND, NSPR, TBIO, BBRY